Clinical features and course of Kawasaki disease in central Tunisia: A study about 14 cases collected over a period of three years (2000-2002);La maladie de Kawasaki au centre Tunisien: Aspects cliniques et evolutifs de 14 cas colliges en trois ans (2000-2002)

Tunisie Medicale

Volumn 83, Issue 8, 2005, Pages 477-483

  Jalel, Chemli ^a   Habib, Kchaou ^a   Fethi, Amri ^b   Adel, Belkadhi ^c   Sahloul, Essoussi Ahmed ^d   Neji, Gueddiche ^e   Abdelaziz, Harbi ^a  

^a SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

^b Hopital Regional de Kairouan   (Tunisia)

^c Service de gynéco obstétrique hôpital régional de Nabeul   (Tunisia)

^d FARHAT HACHED HOSPITAL   (Tunisia)

^e FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Child; Coronary aneurysm; Kawasaki disease; Muco cutaneous lymph node syndrome; Prolonged fever

Indexed keywords

ACETYLSALICYLIC ACID; CARBAMAZEPINE; CLONAZEPAM; DIPYRIDAMOLE; IMMUNOGLOBULIN; VEINOGLOBULINES; VIGABATRIN;

APHASIA; ARTHROPATHY; ARTICLE; BEHAVIOR DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CORONARY ARTERY ANEURYSM; CORONARY ARTERY THROMBOSIS; DISEASE COURSE; FEMALE; FOCAL EPILEPSY; HEART DISEASE; HUMAN; MALE; MITRAL VALVE REGURGITATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERICARDITIS; TUNISIA; URINARY TRACT DISEASE;

AGE FACTORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME; TUNISIA;

EID: 26844526316     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kawasaki T.: Mucocutaneous lymph node syndrome: clinical observations of 50 cases. Jap. J. Allergol., 1967; 16: 178-82.
2. Gaudelus J., Guillois B., Paries J. et le groupe de pathologie infectieuse pédiatrique. Le syndrome de Kawasaki en France. Enquête rétrospective sur 5 ans. Méd. Mal. Infect., 1998; 28: S542-S549.
3. Chemli J, Bouguila J, Zouari N et al. Maladie de Kawasaki à propos de deux observations. Rev. Maghr. Pediatr., 2000; 10: 259-64.
4. Bowen K., DE Graeff Meeder E.R., Spliet W., Kuis W. Atypical Kawasaki disease: an often missed diagnosis. Eur. J. Pediatr., 1992; 51: 577-80.
5. Avner J.R., Shaw K.N., Chin A.J. Atypical presentation of Kawasaki disease with early development of giant coronary artery aneurysms. J. Pediatr., 1989; 114: 605-8.
6. Gaudelus J., Belasco C., Ovtchkine P., Camard O. Syndrome de Kawasaki. Rev. Prat., 1997; 47: 1442-6.
7. Rodiere M. Syndrome de Kawasaki: formes incomplètes ou atypiques du syndrome. Méd. Mal. Infect., 1998; 28: 568-71.
8. Rowe RD, Rose V. Kawasaki disease: Canadian update. Can. Med. Assoc. J., 1985;132:25.
9. Takara K, Susakawa S. Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study. J. Pediatr., 1987; 111:705-10.
10. Grimprel E., Najib J., Tillous-borde I. et al. Complications cardiaques du syndrome de Kawasaki. Etude rétrospective effectuée à l'hôpital Trousseau , 1987-1993. Méd. Mal. Infect., 1998; 28: 591.
11. Kato H., Ichinose E., Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J. Pediatr., 1986; 108:923-7.
12. Capannari TE., Daniels SR, Meyer RA., Schwartz DC., Kaplan S. Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J. Am. Coll. Cardiol., 1986; 7:355-60.
13. Nakano H., Ueda K., Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am. J. Cardiol. 1985;56:846-51.
14. Akagi T., Rose V., Benson LN., Newman A., Freedom RM. Outcome of coronary artery aneurysms after Kawasaki disease. J. Pediatr., 1992; 121:689:-94.
15. Suzuki A., Kamiya T., Arakaki Y., Kinosshita Y., Kimura K. Fate of coronary arterial aneurysms in Kawasaki disease. Am. J. Cardiol., 1994; 74:822-4.
16. Sugimura T., Kato H., Inoue O, Fukuda T. et al. Intravascular ultrasound of coronary arteries in children. Assessment of wall morphology and the lumen after Kawasaki disease. Circulation, 1994; 89:258-65.
17. Iemura M., Ishii M., Sugimura T., Akagi T., Kato H. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart., 2000; 83:307-11.
18. Brogan P.A., Bose A., Burgner D. et al. Kawasaki disease: an evidence based approch to diagnosis, treatment, and proposals for future research. Arch. Dis. Child., 2002; 86:286-90.
19. Rosenfeld E.A., Corydon K.E., Shulman S.T. Kawasaki disease in infants less than one year of age. J. Pediatr., 1995, 126:524-9.
20. Kato H., Hoike S., Yamamoto M. et al. Coronary aneurysm in infants and young children with acute febrile mucocutaneous lymph node syndrome. J. Pediatr., 1975; 86:892-8.
21. Terasawa K., Ichinose E., Matsuishi T., Kato H. Neurological complications in Kawasaki disease. Brain Dev., 1983; 5:371-74.
22. Suda K., Matsumura M., Ohta S. Kawasaki disease complicated by cerebral infartion. Cardiol. Young., 2003; 13:103-5.
23. Larralde M., Santos-Munoz A., Rutiman R. Kawasaki disease with facial nerve paralysis. Pediatr. Dermatol., 2003; 20:511-3.
24. Watanabe T., Iwabuchi H. Rabdomyolysis in a patient with Kawasaki disease. Eur. J. Paediatr., 2003; 162:891-2.
25. Kawasaki T., Kosaki F., Okawa S. et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54: 271-6.
26. Yanagagawa H., Yashiro M., Nakamura Y. et al. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch. Adolesc. Med., 1995; 149: 779-83.
27. Floret D. Le syndrome adéno-cutanéo-muqueux. Arch. Fr. Pediatr., 1983; 40:665-8.
28. Zhang T., Yanagawa H., Oki I., Nakamura Y. Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset. Acta Paediatr., 2002;91:517-20.
29. Newberger J.W., Takahashi M., Burn J.C. et al. The treatment of Kawasaki syndrome with intravenous gammaglobulin. N. Engl. J. Med., 1986; 315: 341-7.
30. Astruc J. Syndrome de Kawasaki et immunoglobulines intraveineuses. Alternatives thérapeutiques. Méd. Mal. Infect., 1998; 28: 586-9.
31. Durongpisitkul K., Gururaj V.I., Park J.M. et al. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of Aspirin and immunoglobulin treatment. Pediatrics, 1995; 96: 1057-61.
32. Carriere J.P., Chaix Y., Grouteau E. Le traitement anti-inflammatoire dans le syndrome de Kawasaki. Méd. Mal. Infect., 1998; 28: 581-5.
33. Sundel R.P., Burns J.C., Baker A., Beiser A. Gamma globulin re-treatment in Kawasaki disease. J. Pediatr., 1993; 123:657-9.
34. Hashimoto K., Ishii M., Iemura M. et al. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr. Int., 2001; 43:211-7.